News and Events
The University of Minnesota College of Pharmacy mourns the loss of Don Uden, PharmD, professor in the Department of Pharmaceutical Care & Health Systems, who died on Saturday, March 21.
The University of Minnesota College of Pharmacy has ranked third in this year’s U.S.News and World Report’s ranking of pharmacy schools.
Last month, VALTOCO — a nasal diazepam spray designed as a rescue therapy for patients with epilepsy who have seizure clusters — received FDA approval.
Congratulations to Dr. Reena Kartha who was selected to serve as a member of the CureGPX4 Science Team!
Sarah Kim has been awarded the Frieda M. Kunze Fellowship for the 2020-21 academic year. Receipt of this compettive award is a tribute to her excellent academic record and professional promise. Sarah is working in the rare disease and orphan drug area, and Dr. Cloyd serves as a member of her PhD committee. Congratulations Sarah!
James Cloyd III, PharmD, has been selected to receive the 2020 Tyler Prize for Stimulation of Research. The award recognizes an individual for encouraging research by peers, students, fellows, residents and others via publications or by directing research, serving as a preceptor, or mentoring in any discipline of the pharmaceutical sciences.
Dr. Kartha accepts invititation from the Gaucher Community Alliance to join their new Professional Advisory Council.
The Rare Disease Legislative Advocates (RDLA) announced Erica Barnes as one of the 2019 RareVoice Awards state advocacy finalists. Erica Barnes is the council administrator of the Chloe Barnes Rare Disease Advisory Council and a member of the University of Minnesota Rare Disease Day planning committee. The RareVoice Awards is an annual celebration, now in its eighth year, to honor advocates who give rare disease patients a voice on Capitol Hill and in state government.
Dr. Kartha has joined the Board of Directors for IndoUSrare. Her role will be to accelerate clinical research leading to faster diagnostics, cures for rare diseases by engaging US sponsors and CROs to include India in their clinical trials and foster collaborations between patient advocacy groups and researchers in the USA and India to help accelerate clinical research, trials and therapy access across borders.